Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases
- 1 November 1994
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 344 (8932), 1255-1260
- https://doi.org/10.1016/s0140-6736(94)90750-1
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cancer chemotherapy and quality of life.BMJ, 1992
- Statistical analysis of longitudinal quality of life data with missing measurementsQuality of Life Research, 1992
- Regional infusion chemotherapy for colorectal hepatic metastases—where is it going?Cancer Treatment Reviews, 1991
- Intra-arterial Floxuridine vs Systemic Fluorouracil for Hepatic Metastases From Colorectal CancerArchives of Surgery, 1990
- Resection of Hepatic Metastases from Colorectal Cancer Biologic PerspectivesAnnals of Surgery, 1989
- Hepatic metastases from colorectal cancer: Resection or notBritish Journal of Surgery, 1988
- A Prospective Randomized Trial of Regional Versus Systemic Continuous 5-Fluorodeoxyuridine Chemotherapy in the Treatment of Colorectal Liver MetastasesAnnals of Surgery, 1987
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983
- Prognostic factors in advanced colorectal carcinoma: Importance of lactic dehydrogenase level, performance status, and white blood cell countAmerican Journal Of Medicine, 1983
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977